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The Conserved Oligomeric Golgi complex is an evolutionarily conserved multisubunit
tethering complex (MTC) that is crucial for intracellular membrane trafficking and
Golgi homeostasis. The COG complex interacts with core vesicle docking and fusion
machinery at the Golgi; however, its exact mechanism of action is still an enigma. Previous
studies of COG complex were limited to the use of CDGII (Congenital disorders of
glycosylation type II)-COG patient fibroblasts, siRNA mediated knockdowns, or protein
relocalization approaches. In this study we have used the CRISPR approach to generate
HEK293T knock-out (KO) cell lines missing individual COG subunits. These cell lines were
characterized for glycosylation and trafficking defects, cell proliferation rates, stability of
COG subunits, localization of Golgi markers, changes in Golgi structure, and N-glycan
profiling. We found that all KO cell lines were uniformly deficient in cis/medial-Golgi
glycosylation and each had nearly abolished binding of Cholera toxin. In addition, all cell
lines showed defects in Golgi morphology, retrograde trafficking and sorting, sialylation
and fucosylation, but severities varied according to the affected subunit. Lobe A and
Cog6 subunit KOs displayed a more severely distorted Golgi structure, while Cog2, 3,
4, 5, and 7 knock outs had the most hypo glycosylated form of Lamp2. These results
led us to conclude that every subunit is essential for COG complex function in Golgi
trafficking, though to varying extents. We believe that this study and further analyses of
these cells will help further elucidate the roles of individual COG subunits and bring a
greater understanding to the class of MTCs as a whole.
Keywords: COG complex, Golgi apparatus, CRISPR, vesicle tethering, glycan processing, glycosylation, toxin
trafficking
INTRODUCTION
Efficient docking and fusion of intracellular transport carriers in eukaryotic cells is tightly regulated
by a family of multi-subunit tethering complexes (MTC) that sequentially and/or simultaneously
interact with other components of vesicle docking and fusion machinery (Lupashin and Sztul,
2005; Yu and Hughson, 2010). The Conserved Oligomeric Golgi (COG) complex, the main MTC
functioning at the Golgi, is a key player in intra-Golgi retrograde trafficking (Suvorova et al.,
2002; Ungar et al., 2002; Miller and Ungar, 2012; Willett et al., 2013a,b). The COG complex is
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a hetero-octamer and a member of the CATCHR (complexes
associated with tethering containing helical rods) family of
proteins (Yu and Hughson, 2010). It is comprised of eight
different protein subunits (named Cog1–8) (Whyte and Munro,
2001; Ungar et al., 2002) that are organized into two functionally
distinct sub complexes or lobes: Cog1–4 in lobe A and Cog5–
8 in lobe B (Fotso et al., 2005; Ungar et al., 2005). The two
lobes are bridged together via an interaction between lobe A
subunit Cog1 and lobe B subunit Cog8 (Fotso et al., 2005;
Ungar et al., 2005). Previous studies on the interactome of
the COG complex have revealed protein-protein interactions
with several different families of trafficking regulatory proteins
including SNAREs, SNARE-interacting proteins, Rab GTPases,
coiled-coil tethers, and COPI subunits (Suvorova et al., 2002;
Shestakova et al., 2006, 2007; Sohda et al., 2007, 2010; Sun
et al., 2007; Miller et al., 2013; Willett et al., 2013a, 2014).
Further studies revealed that the COG complex is required for
the proper recycling of Golgi localized glycosylation enzymes
(Kingsley et al., 1986; Podos et al., 1994; Shestakova et al., 2006;
Steet and Kornfeld, 2006; Pokrovskaya et al., 2011; Cottam et al.,
2014). In humans, mutations in COG complex subunits result
in type II congenital disorders of glycosylation (CDG-II; Wu
et al., 2004; Foulquier et al., 2006, 2007; Kranz et al., 2007;
Paesold-Burda et al., 2009; Reynders et al., 2009; Ungar, 2009;
Lübbehusen et al., 2010; Kodera et al., 2015). These COG complex
deficiencies cause many developmental impairments including
microcephaly, mental retardation, hypotonia, and issues with
hemostasis (for review see Climer et al., 2015; Rymen et al., 2015).
In addition to its roles in glycosylation and Golgi homeostasis,
the COG complex is also hijacked by intercellular pathogens
such as HIV and Chlamydia (Pokrovskaya et al., 2012; Liu et al.,
2014). COG complex mutants have been found in a variety of
model organisms including plants, fruit flies, worms, and yeast,
but the phenotypes between these different model organisms vary
greatly. In humans, COG complex function has been studied
through case studies of CDGII-COG patients, patient fibroblasts
in cell culture (which have limited proliferation potential, and
may still have small amounts of mutant COG protein), or by
using knock down and knock sideways assays in immortalized
cell lines. Though these approaches have proved useful, they fail
to allow for study of the long term effects of COG loss.
In the present study we report on a set of immortalized COG
subunit KO cell lines made using CRISPR/Cas9 technology in
HEK293T cells. These cells have allowed us to begin elucidating
contributions of each subunit to overall complex function and
stability, and also to probe the COG complexes’ vast interactome
for unique interacting partners and functions of the various
subunits.
METHODS
Reagents and Antibodies
Reagents were as follows: GNL-Alexa 647 (Willett R. A.
et al., 2013), RCAI-Rho (Vector Labs), CTxB-Alexa 647
(Molecular Probes), Subtilase cytotoxin (1.49 mg/ml; Paton et al.,
2004). Antibodies used for immunofluorescence microscopy
(IF) or western blotting (WB) were purchased through
commercial sources, gifts from generous individual investigators,
or generated by us. Antibodies (and their dilutions) were
as follows: rabbit affinity purified anti-hCog3 (WB 1:10,000;
Suvorova et al., 2001), hCog4 (WB 1:1000, this lab), hCog6 (WB
1:1000, this lab), hCog8 (WB 1:1000, this lab); mouse monoclonal
anti-LAMP2 (WB 1:100, DSHB), anti-Cathepsin D (WB 1:500,
Sigma), anti-GM130 (WB 1:1000, BD), and goat anti-GRP78
(WB goat 1:1000; Santa Cruz).
Cell Culture, Transfection, and Media
Collection
HEK293T cells (ATTC) were grown in DMEM/F12 medium
(Thermo Scientific) supplemented with 10% FBS (Atlas
Biologicals) and in the presence of antibiotic/antimycotics where
noted. Cells were kept at 37◦ and 5% CO2 in a 90% humidified
incubator. Cells were passaged via gentle resuspension.
HEK293T Cog1 through Cog8 stable knockouts were
generated using CRISPR technique (Jinek et al., 2012; Cong et al.,
2013; Mali et al., 2013). gRNA sequences were either provided
by Horizon Discovery or purchased from Genecopoeia. From
Horizon: Cog8 Guide ID:123842 Target: GGTGGAGGATGA
AGGGCTCC, Cog1 Guide ID: 129696 Target: TTTCGAGAC
GCATGGAGCGG, Cog3 Guide ID: 113509 Target: GGCGCT
GTTGCTGCTGCCTG, Cog4 Guide ID: 123995 Target: CGA
ATCAAGGTCCGCCATCT, Cog6 Guide ID: 113368 Target:
GCTGCCAACGGCCTCAACAA. From Genecopia: Cog5
Catalog No. HCP200561-CG01-3-B-a Target: CAACTAGCA
AAACTTGCCCA, Cog2 Catalog No. HCP205454-CG01-3-B-a
Target: CTTGTTGATGAGTTCGACCA, Cog7 Catalog No.
HCP222287-CG01-3-B-b Target: CCAAGAGGTGAACCACGC
CG. HEK293T cells were transfected with plasmid containing
gRNA with Cas9-dasherGFP (Horizon Discovery) or Cas9 with
mCherry (Genecopia).
For transfection with Lipofectamine 2000 cells were plated
on a 6-well plate (one well for each set of plasmids) to reach
a confluency of 50–70% the next day (∼1.5 × 106 cells/well).
Cells were placed in Optimem prior to transfection, the lipid-
DNA complex was added to the cells and cells were allowed to
incubate with the DNA overnight. The media was changed to
regular culture media the following morning. Cells were checked
at the 24 and 48-h time points to evaluate transfection efficiency
(via fluorescence on the CRISPR/Cas9 plasmid).
To obtain conditioned media from the cells to analyze cell
secretions, cells went through the following protocol: Media
was removed then cells were washed with PBS 3x. Serum free,
chemically defined media (BioWhittaker Pro293a-CDM, Lonza)
supplemented with glutamine was then added to the cells and the
cells were incubated at 37◦C and in 5%CO2 for 48 h before media
was collected. Media was then spun at 3000 g to remove any cells
or cell debris. The supernatant was removed and stored at−20◦C
until analyzed by SDS-PAGE and western blot.
Immunofluorescence Microscopy
Cells were grown on 12 mm glass coverslips (#1, 0.17 mm
thickness) 1 day before transfection. After transfection cells were
fixed and stained as described previously (Pokrovskaya et al.,
2011). In short, cells were fixed in 4% paraformaldehyde (16%
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stock solution diluted in Dulbecco’s phosphate-buffered saline
(DPBS); Electron Microscopy Sciences). Cells were then treated
with 0.1% Triton X-100 for 1 min and with 50 mM ammonium
chloride for 5 min. Cells were washed with DPBS and blocked
twice for 10 min with 1% BSA, 0.1% saponin in DPBS. Cells
then were incubated for 1 h with primary antibody diluted in
antibody buffer (1% cold fish gelatin, 0.1% saponin in DPBS)
at room temperature. Cells were washed four times with DPBS
and incubated for 30 min with fluorescently tagged secondary
antibody in antibody buffer at room temperature. Coverslips
were washed four times with DPBS, rinsed with ddH2O, and
mounted on glass microscope slides using Prolong R© Gold
antifade reagent (Life Technologies). Cells were imaged with
the 63X oil 1.4 numerical aperture (NA) objective of a LSM510
Zeiss Laser inverted microscope outfitted with confocal optics.
Image acquisition was controlled with LSM510 software (Release
Version 4.0 SP1). Processing was done using this software as well
as ImageJ.
Lectin Staining and Immunofluorescence
Lectin staining was performed as previously described (Willett
R. A. et al., 2013) with minor modifications. Cells were seeded
on to collagen coated glass. When cells were 75–100% confluent
coverslips were removed and washed with warm PBS then fixed
in 1% paraformaldehyde in PBS for 15 min followed by a
wash and a 10-min block with 1% BSA in PBS. The blocking
step was repeated, then cells were incubated with the lectin
diluted 1:1000 in 1% BSA solution for 30–60 min. Cells were
washed 5 times and fixed for 15 min with 4% paraformaldehyde
in DPBS for intracellular staining. The above protocol for
traditional immunofluorescence to look at intracellular proteins
was followed with an optional urea treatment (2–3 min) prior to
blocking for better antibody binding.
Flow Cytometry
Cells were grown to 80–100% confluency then resuspened in ice
cold 0.1% BSA by gentle pipetting and placed in an Eppendorf
tube. Cells were pelleted at a low speed (600 g for 3 min) and
resuspended in 0.1% BSA containing the lectin of choice (GNL,
Ricin, or Cholera toxin) at a 1:1000 dilution. Cells were incubated
in lectin solution on ice for 30–60 min. Cells were then spun
down and resuspended in ice cold 0.1% BSA (plus DAPI for
viability gaiting) by gentle pipetting. Cells were analyzed using
the NxT Attune flow cytometer. Cells were gated for live cells
(DAPI excluding cells), singlets, then for correct cell size vs.
complexity. Analysis was done using FlowJo software.
Cell Sorting and Colony Expanding
For cell sorting, lectin staining was done as detailed above. Cells
were spun down at a 600 g then resuspended in cell sorting media
[PBS, 25 mM Hepes pH = 7.0, 2% FBS (heat inactivated) 1 mM
EDTA, 0.2 µm sterile filtered] and filtered through a filtered
cap 5 ml- 12 × 75 mm polystyrene round bottom tube before
single cell sorting. Sorting was based on high-GNL-Alexa 647
fluorescence into a 96-well plate containing culture medium plus
antibiotic/antimycotics. Cell sorting was done using FACSARIA
at the UAMS Flow Cytometry core facility.
The 96-well plates were analyzed for colonies 10–14 days after
sorting. Wells with colonies were marked and allowed to grow
for 1 week more before expanding. After 21 days, colonies were
expanded from 96-well to 12-well plates via resuspension. Cells
were maintained in antibiotic/antimycotic media and allowed to
grow further. Once colonies were split onto 10 cm dishes (around
4–6 weeks after initial transfection) aliquots were cryopreserved
in freezing media (90% FBS plus 10% DMSO) and the remaining
cells were used for other analysis, including sequencing, western
blot, and flow analysis.
Chromosomal DNA Prep, PCR, and
Sequencing
For chromosomal DNA prep cells were resuspended in culture
media and an aliquot was taken for counting. After cell density
was determined 100,000 cells were removed and placed into a
microcentrifuge tube. Cells were spun down at low speed (600 g
for 3 min) and resuspended in PBS then spun down again. 0.5 mL
of Quick Extract DNA extraction solution was added then cells
were resuspended via vortex. Cells were placed at 63◦C for 8 min,
vortexed and placed at 98◦C for 2 min per the manufacturer’s
instructions. Chromosomal DNA was stored at−20◦C until use.
PCR using chromosomal DNA as a template was done for a
300–800 base pair region surrounding the CRISPR cut site. Two
50µL reactions were done for each potential knock out cell line as
well as two reactions of a wild type control for each. Each reaction
contained the following: 2 mM each of targeted COG subunit
forward and reverse primer, 2–3 µL of the chromosomal DNA,
2.5µL of DMSO, 4µL of dNTPs, 5µL of 5x exTaq buffer, and 0.2
µL of exTaq polymerase. Reactions were run with the following
settings:
1. 95◦C, 1:00 min
2. 95◦C, 0:10
3. 57◦C, 0:10
4. 72◦C, 0:30
5. Repeat 2–4, 35x
6. 6 72◦C, 0:30
7. 4◦C,∞
Reaction products were then gel purified using a Gel Extraction
kit (Zymo Reaserch) and following the manufactures protocols.
Samples were then sent for sequencing at the UAMS DNA
Sequencing core facility.
Subtilase Cytotoxin Assay
Subtilase cytotoxin (SubAB) assay was essentially performed as
in Smith et al. (2009) with minor modifications. Both control
and COG KO HEK293T cells were grown on 12-well culture
plates to 70–80% of confluency. Cells were placed in 10% FBS
in DMEM/F-12 (50:50) without antibiotics and antimycotics
for at least 1 h before the assay was performed. The subtilase
cytotoxin was diluted in the same medium (without antibiotic)
and warmed up to 37◦C. The time course is 0-, 20-, 40-, 60- 120-,
and 180-min. Cells were incubated with the subtilase cytotoxin
(0.05 µg/ml for the appropriate times in the 37◦C incubator
with 5% CO2). Cells were then washed off with PBS and lysed
with 2% SDS warmed up to 95◦C. Cell lysates, 10 µl of each,
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were loaded on a 4–15% gradient gel and immunoblotted with
anti-GRP78 (Santa Cruz; C-20) antibody. All experiments were
performed in triplicates. The blots were scanned and analyzed
with an Odyssey Infrared Imaging System (LI-COR, Lincoln,
NE).
High Pressure Freezing, Freeze
Substitution, and Electron Microscopy
Sapphire disks were carbon coated then collagen coated
(Corning) per the manufacturer’s instructions. Disks were then
sterilized under UV light and transferred to new sterile 3
cm dishes (one dish with 3 disks per sample), cells were
plated on top and allowed to grow until a confluency of 80–
100% was reached on the disks. The media was then changed
for each of the plates to fresh culture media and cells were
allowed to incubate at 37◦C for 2–3 h before high pressure
freezing. Disks containing cells were high pressure frozen in
cryoprotectant (PBS with 2% agarose, 100 mM D-mannitol, and
2% FBS) using a Leica EM PACT2 high pressure freezer with
rapid transfer system, then transferred under liquid nitrogen
into tubes containing a staining cocktail (acetone with 2%
osmium tetroxide, 0.1% Glutaraldehyde, and 1% ddH2O) pre
frozen in liquid nitrogen as well. Tubes were then transferred
to a freeze substitution chamber at −90◦C on the following
schedule: −90◦C for 22 h, warm 3◦C/h to −60◦C, −60◦C for
8 h, warm 3◦C/h to −30◦C, −30◦C for 8 h, warm 3◦C/h
to 0◦C.
Sample tubes were then placed on ice and washed with
acetone 3x. Samples were than stained with a 1% Tannic acid/1%
ddH2O solution in acetone on ice for 1 h before three more
acetone washes. Samples were than stained with a 1% osmium
tetroxide/1% ddH2O solution in acetone on ice for 1 h then
washed three more times in acetone before the embedding
process.
Samples were embedded in Araldite 502/Embed 812 resin
(EMS) with DMP-30 activator added in a Biowave at 70◦C
under vacuum for 3 min for each embedding step. Samples were
then baked at 60◦C for 48 h before sectioning. Samples were
stained post sectioning with uranyl acetate and lead citrate before
imaging. Ultrathin sections were imaged at 80 kV on a FEI
Technai G2 TF20 transmission electron microscope and images
were acquired with a FEI Eagle 4kX USB Digital Camera.
Cell Lysis and Western Blot
Media was removed from one well of a 6-well plate (cells at∼90%
confluency) for each cell line and cells were washed gently with
PBS. Cells were resuspended in PBS via gentle resuspension and
placed into amicrocentrifuge tube. Cells were then pelleted at 600
g for 3 min. PBS was removed and 250 µL of 95◦C 2% SDS was
added to lyse cells. The mixture was vortexed and heated at 95◦C
for 5 min. Fifty microliters of 6x sample buffer containing 5% β-
mercaptoethanol was added and vortexed. Samples were stored
at−20◦C until use.
For western blot analysis 10–15 µL lysates were added to
wells a 4–15% gradient gel. The gel was then run at 180 V
until the dye reached the bottom. Proteins were transferred to
a nitrocellulose membrane. The membrane was stained with
Ponceau S Stain and a picture was taken. Themembrane was then
washed and blocked for 20 min. Primary antibodies in blocking
buffer were added and the membrane was incubated overnight
at 4◦C. The following day the membrane was washed 3x and
incubated with secondary antibody in 5% evaporated milk in
PBS for 40 min. Membrane was washed 4x and imaged using
the Odyssey imaging system. Analysis was done in Licor Image
Studio light.
Glycan Sample Preparation and Mass
Spectrometry
Procedure was performed as in Abdul Rahman et al. (2014) with
some modifications.
In brief, cells were grown to 80–90% confluency. Media was
removed and cells were washed 5x with PBS. Cells were then
resuspended in PBS via gentle pipetting and placed on ice. Cells
were then spun down at 14,000 g for 5 min. PBS was then
removed and more was added. Cells were spun down again then
the supernatant was removed. Glycan lysis buffer (4% (w/v) SDS,
100 mM Tris/HCl pH 7.6, 0.1 M dithiothreitol) was added in a
1:10 pellet/lysis buffer volume ratio. The sample was heated to
95◦C for 5 min. The lysate was centrifuged at 14,000 g for 10 min,
and the supernatant was collected and kept at−80◦C.
Filter-aided N-glycan separation (FANGS) was performed as
described (Abdul Rahman et al., 2014). Specifically, following
dilution in urea buffer (8 M urea, 100 mM Tris/Cl, pH
8.5) the lysate was transferred into a 30 kDa ultrafiltration
tube (Millipore). Subsequently repeated centrifugations and
dilutions with urea buffer were performed interspersed with an
iodoacetamide treatment (40 mM in 300 µL urea buffer). Finally,
the membrane filter was washed three times with ammonium
bicarbonate (50 mM, pH 8.0), and the sample treated with 8
units of PNGase F in 100 µL ammonium bicarbonate buffer
for 16 h at 37◦C. Glycans were eluted from the filter by
centrifugation followed by a wash in HPLC grade water. Released
N-glycans were dried and permethylated in alkaline DMSO using
iodomethane and dried as described (Abdul Rahman et al., 2014).
Permethylated N-glycans were dissolved in 20 µL of methanol,
2 µL of this solution was then mixed with 2 µL of 20 mg/mL
2,5-dihydroxybenzoic acid (DHB) in 70% methanol and 1 µL of
sodium nitrate (0.5M), spotting 2µL of this onto aMALDI target
plate. Mass spectra were acquired on a 9 T solariX FTICR mass
spectrometer (Bruker Daltonics) recorded over the m/z range
400–4000 in positive ion mode with 500 laser shots. Eight scans
were averaged and the laser power was set between 30 and 40%.
Spectra were calibrated externally using a Bruker Peptide Mix
II. N-glycans were identified by their accurate mass and isotope
pattern, and included in the analysis if at least two isotope peaks
were above a signal to noise ratio of three. Glycan intensities were
calculated by summing the peak area divided by the half maximal
width for each isotope. Relative quantification was achieved by
normalizing glycan intensities within each spectrum to the sum
of intensities for the glycan species observed in all analyzed
cell lines. Relative abundances were averaged from biological
replicates and error bars indicate the standard error of the
mean.
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RESULTS
Cells Deficient in COG Complex Subunits
Express an Increased Amount of Terminal
High Mannose Residues on the Plasma
Membrane
N-glycosylation begins in the ER where the forming glycan
chains are added to nascent proteins. The glycoprotein is then
modified and transferred to the Golgi where the oligomannose
type glycans, which contain terminal mannose residues, are then
trimmed and processed. This process, which continues as the
protein progresses through the Golgi, leads to hybrid then finally
mature, complex oligosaccharides (Stanley, 2011).
Our group has previously shown that COG complex subunit
knock downs (KD) in HeLa and HEK293T cells cause altered
binding of several lectins due to impaired glycosylation of plasma
membrane glycoconjugates while in the Golgi (Shestakova et al.,
2006; Richardson et al., 2009; Pokrovskaya et al., 2011; Willett
FIGURE 1 | COG KO validation. Left column: Sequence alignment of mutant and control DNA. Chromosomal DNA was amplified at the CRISPR target region by
high fidelity PCR. The expected cut site based on the guide RNA is highlighted in yellow. The central column shows plasma membrane staining of WT HEK293T and
COG KO cells with Galanthus nivalis lectin (GNL-pink). Nuclei stained with DAPI (blue). Right column: cells were analyzed using flow cytometry for GNL staining
(wild-type cells are in black, COG KO cells are in white).
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R. A. et al., 2013; Ha et al., 2014). We used this knowledge to
screen HEK293T cells subjected to CRISPR/Cas9–based gene
editing to isolate COG KOs. For this preliminary screen we
chose Galanthus nivalus lectin conjugated with Alexa 647 (GNL-
647) as a tool for selection. GNL binds to terminal α1-3 linked
mannose residues (Shibuya et al., 1988) to all tested COGKD cells
(Pokrovskaya et al., 2011) making it a helpful probe for immature
glycans. By treating non-permeabilized cells with fluorescently
tagged GNL, only immature glycans on the cell surface bind the
lectin, making cells with glycosylation defects easy to sort from
the transfected population.
Preliminary analysis revealed that 8 days after transfection
with individual COG-subunit-specific CRISPR constructs a
subpopulation of cells (around 5% of the total population)
appeared that have high GNL binding compared to control
cells (data not shown). From the 5% GNL positive population
observed by flow cytometry, presumed COG KO cells were
single cell sorted into a 96 well plate. Each plate yielded ∼10–15
individual colonies. On the secondary GNL binding test several
colonies demonstrated diminished GNL staining (∼3 for each
plate) and these clones were always still positive for the targeted
subunit and served as an internal control. We preserved at
least 2–5 Cog negative clones for each subunit KO as assessed
by high GNL binding (assessed by IF, Figure 1). For further
confirmation of COG KO induced high GNL binding, flow
analyses were performed on these clones. KO cells labeled with
GNL-647 revealed a uniform, bright plasma membrane staining
that was distinct from control HEK293T cells (Figure 1). This
increased amount of plasma membrane glycoconjugates with
terminal α1-3 linkedmannose residues indicates altered activities
in cis-Golgi Mannosidase I enzymes (MAN1A1, MAN1A2,
MAN1C1) as well as in cis/medial-Golgi localized Mannosidase
II (MAN2A) and/or GlcNAc-T1 (MGAT1) transferase that were
shown previously to be COG complex dependent (Pokrovskaya
et al., 2011). From this we concluded that GNL binding is a
powerful selection strategy for phenotypic sorting of all COG
subunits KOs. Clonal populations of COG KOs were further
validated by sequencing and western blot (Figures 1, 2). Because
all CRISPR gRNA sequences were designed to target the first
exon of COG genes, we have amplified the first exon from
chromosomal DNA extracted from both control and KO cells
with high-fidelity PCR. Sequencing of resulted PCR products
revealed significant deletions and/or mutations in the first exon
of each of targeted genes (Figure 1). We also confirmed a
FIGURE 2 | Growth and rescue of COG KO cells. (A) Growth of WT and KO cells. Cells were plated in 24 well plates in triplicate at 100,000 cells per well (Day 0).
Cells were counted at the indicated time points over a week and cell counts were plotted. (B) The average growth in a 24 h period was calculated by (# of cells on day
n/ # of cells on day n-1)*100 to get percent growth per day. Growth percentages over the week for each cell line were averaged. (C) Western blot analysis for each
COG subunit KO cell line. β-actin is used as a loading control. Asterisks indicate non-specific bands. (D) Rescue of COG dependent glycosylation defect. Missing
COG subunits (green) were transfected into KO cells. Seventy two hours later cells were fixed and stained with GNL-Alexa 647 (pink). Note that GNL binding was
significantly reduced in cells expressing COG subunits.
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complete loss of corresponding COG subunits by Western blot
(WB) for Cog2–8 KOs (Figure 2C).
Because antibodies for Cog1 are currently not available for
western blot, we next sought to further validate this cell line
and others by rescuing the glycosylation defects by transient
expression of the myc-tagged knocked-out COG subunit
(Figure 2D). Four days after transfection, each replacement COG
subunit was observed on the Golgi in cells receiving the plasmids.
These cells also showed WT (decreased) levels of GNL-647
binding to plasma membrane in contrast to their untransfected
neighbors (Figure 2D). This rescue further validated the COG
KO cell lines and supports the idea that cis/medial-Golgi
glycosylation is dependent on the entire COG complex and that
this is not an off target effect of our CRISPR protocol.
To further characterize the COG KO cell lines and test
if aberrant glycosylation or impairment of COG-dependent
interactions affected cell growth, cell proliferation was tracked
(Figures 2A,B). Surprisingly cell lines showed no change from
wild-type HEK293T cells in proliferation rates indicating that, in
HEK293T cells, every COG complex subunit is not essential for
cell growth and division.
To probe for the stability of remaining COG subunits in the
absence of individual subunits, lysates of KO and WT cells were
separated on SDS-PAGE and probed for antibodies to Cog3, 4,
5, 6, 7, and 8 (Figure 3A). (We were not able to include Cog1
due to lack of working antibodies. Cog2 was also omitted from
this assay due to lack of sufficient amounts of this antibody
to perform quantification). We have found that Cog3 and 4
protein levels were drastically impacted in Cog2, 3, and 4 KO
cells indicating that these subunits are only stable in the context
of lobe A subcomplex. Similar situation was observed for lobe B.
Cog6 protein level was reduced in Cog5, 6, and 7 KO (Figure 3B).
Interestingly Cog5 and 7 protein levels appear to be decreased
to <10% when the other protein is knocked out confirming our
previous conclusion that interaction between these two partners
is essential for their stability (Ha et al., 2014). Cog8 protein levels
were reduced upon lobe partner loss but to a far less extent,
indicating that Cog8 gains stability from other partners as well,
likely from its interaction with Cog1. Cog1 interacts with Cog8,
and this interaction is responsible for bridging the two lobes
(Oka et al., 2005; Ungar et al., 2005). Cog proteins in opposing
lobe KOs were occasionally reduced, but the reduction was never
more than 45%, further supporting the bi-lobed model. We have
summarized the supposed subunit interaction based on these
assays in Figure 3C.
Cells Deficient in the COG Complex
Subunits Have an Altered Golgi
Morphology
We next investigated changes in Golgi structure in cells deficient
for individual COG subunits. It has been previously shown that
Golgi morphology was altered in both fibroblasts from COG-
CDG patients (Reynders et al., 2009; Kudlyk et al., 2013) and
in HeLa cells treated with siRNA to COG subunits (Zolov and
Lupashin, 2005; Shestakova et al., 2006). The defects associated
with the Golgi morphology were most notable in lobe A KDs.
FIGURE 3 | COG protein stability upon loss of other COG proteins. (A)
All COG KO cells were probed by western blot for Cog3, 4, 5, 6, 7, and 8
protein levels. β-actin used as a loading control. (B) Quantification of 2
separate western blot analyses. Each Cog protein amount was first
standardized to β-actin then compared to WT levels. (C) A model of COG
subunit interactions. lobe A is shown in shades of red and lobe B is shown in
shades of green. Cog1 and Cog8 are lighter in color to show that they also
gain stability from one another in addition to their lobe partners.
To study Golgi morphology in COG KO cells we subjected
cells grown on sapphire disks to high pressure freezing/freeze
substitution fixation prior to embedding and sectioning for
electron microscopy (EM) analysis. As shown in Figure 4, the
Golgi structure is severely distorted in all knock outs compared
to control. Golgi cisternae appear dilated and fragmented in all
cases, especially in lobe A and in Cog6 KOs (Figure 4, Cog1–4,
6 KOs, arrows). In these cells even Golgi mini-stacks appeared
to be disrupted with appearance of multiple autophagosome-like
membrane profiles in the Golgi region (Figure 4, arrowheads).
In other lobe B KO cell lines strongly dilated Golgi membranes
were organized in mini-stacks with the least severe defect
observed in Cog5 KO cells (Figure 4, Cog5, 7, 8 KOs, arrows).
The morphological changes in the Golgi structure observed in
HEK293T KO cell lines appeared to be on par (or possibly even
more severe) compared to previously described Cog1 and Cog2
deficient CHO cells (Ungar et al., 2002; Oka et al., 2004; Vasile
et al., 2006). Surprisingly this alteration in Golgi structure is only
readily apparent via EM. IF analysis of a comprehensive set of
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FIGURE 4 | Golgi structure is severely distorted in COG KO cells. Cells were grown on carbon and collagen coated sapphire disk then subjected to high
pressure freezing and freeze substitution. Samples were stained with tannic acid and osmium before embedding then uranyl acetate and lead citrate staining post
sectioning. Arrows indicate Golgi stacks. Arrowheads indicate autophagosomal like structures.
Golgi and other secretory protein markers including ERGIC53,
GM130, Golgin 84, GalT, p230, Mannose-6-phosphate receptor,
Lamp2, and TGN46 in COG4 KO and COG7 KO cells, shows a
normal and/or perinuclear distribution, aside from Lamp 2which
localized on large endosomal-like inclusions as well as the normal
lysosome distribution (Figure 5 and data not shown).
Cells Deficient in the COG Complex Show
Altered Toxin Binding at the Plasma
Membrane
The COG complex is a key player in retrograde trafficking, so
we reasoned that intra-Golgi retrograde trafficking should be
impaired in cells lacking COG subunits. To test this cell lines
were analyzed for their ability to traffic various toxins. Toxins
commonly intoxicate a cell by binding to receptors on the plasma
membrane then hijacking the hosts’ secretory pathway to reach
their functional location. For these assays we chose to use one
to two KOs for each lobe to represent the lobe as a whole
(we felt this was warranted based on KOs destabilizing their
lobe partners, Figure 3). The first toxin we attempted to use
for retrograde trafficking analysis was Cholera toxin (which is
secreted byVibrio cholerae and causes the well-known and deadly
effects of Cholera). V. cholerae infects cells by utilizing the B
subunits of Cholera toxin (CTxB) to bind to glycolipid GM1
at the plasma membrane causing the toxin to be endocytosed
(Lencer et al., 1992). Strikingly upon knocking out either lobe A
or lobe B COG subunits, binding and endocytosis of CTxB-Alexa
647 in a 30-min pulse chase was almost completely abolished, a
phenotype that had not been seen in Cog KD cells. In contrast,
wild type cells bind and traffic Cholera toxin to the Golgi after
30 min, visualized by co-localization with GM130 (Figure 6A).
The significant reduction in bound CTxB-647 could also be seen
by flow cytometry of Cog1, 3 and 8 KO cells compared to wild
type populations (Figure 6B). Similarly, it has previously been
shown that GM3 levels are significantly reduced in CHO ldlC
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FIGURE 5 | Golgi and other secretory markers are largely undisturbed in Cog KO cells. Immunofluorescence of Lamp2, Giantin, ERGIC53, TGN46, Vamp3,
and M6PR. Asterisks in Cog7 KO indicate Lamp2-positive, large, endocytic-like structures, Cog4 structures not pictured.
cells (which are deficient for Cog2). This was attributed to the
Cog2 dependent mislocalization of SialT1, which is responsible
for the conversion of LacCer to GM3, in these cells (Spessott et al.,
2010).
For our next toxin binding and trafficking test, Rhodamine
labeled Ricinus communis Agglutinin I (RCA-I) was utilized.
R. communis, or more commonly known as the castor bean
plant, produces two kinds of lectins: R. communis toxin (RCA-
II) (which is well known for its toxicity even at low doses), and
RCA-I which is less toxic, but binds galactose residues with high
affinity. RCA-1 has been shown to bind tumor cells (which also
have altered secretion) with higher affinity than normal cells (You
et al., 2010). Interestingly, knocking out COG subunits in either
lobe caused a modest increase in RCA-I binding, assessed by
fluorescence (Figure 6B). In Cog KO cells RCA-I was also able
to traffic to the Golgi after 30 min, though more remained on
the plasma membrane than in control cells, indicating a possible
delay in retrograde trafficking (Figure 6A).
Cells Deficient in the COG Complex
Subunits Have Altered Intracellular
Trafficking
Due to the differences in binding of CTXB and RCA-I between
wild type and COG KO cell lines that precluded the accurate
measuring of retrograde trafficking efficiency of these proteins
we turned to the Subtilase cytotoxin (SubAB) trafficking assay
(SubAB is a toxin secreted by Shiga-toxigenic Escherichia coli).
Our group has previously used this assay to study retrograde
trafficking in COG knock down cells, and has shown no change
in toxin affinity to plasma membrane of COG depleted cells
(Smith et al., 2009). SubAB binds at the plasma membrane
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FIGURE 6 | COG KO cells are altered for the binding of RCA-I and CTxB to plasma membrane. (A) Pulse chase with labeled toxins was done at 37◦C for 30
min before fixing and staining with GM130 antibodies. Cells were mounted in DAPI containing media. Coverslips were analyzed using a confocal microscope. (B) Cells
were incubated with the toxins on ice for 30 min then processed using a flow cytometer and analyzed in FlowJo.
then is trafficked in a retrograde fashion through the Golgi to
the endoplasmic reticulum where it cleaves its target, GRP78
(Glucose-Related protein of 78 kDa). To explore SubAB transport
in COG KO cells, these cells were treated with the toxin over
time and analyzed via WB for cleavage of GRP78 to smaller
fragments (Figure 7A). In all knock out cell lines tested there
was a dramatic delay in GRP78 cleavage (Figures 7B,C). Half
of GRP78 was cleaved in control HEK293T cells after ∼25
min of toxin treatment, but not until ∼80 min in COG KO
cells (Figures 7B,C). This indicates that retrograde trafficking
is impaired in COG KO cells, but not abolished. Significantly,
the amount of delay appeared similar in each KO tested
regardless of which lobe was affected indicating that the rapid
retrograde trafficking of SubAB is dependent on the whole COG
complex.
COG Deficient Cells Missort Cathepsin D
Next we probed the COG KO cells lacking lobe A or B subunits
for other possible trafficking defects by analyzing conditioned
serum-free, chemically-defined culture media taken after 48 h
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FIGURE 7 | Retrograde trafficking of SubAB is impaired in COG subunit KO cells. (A) Time course of SubAB-dependent cleavage of GRP78 in control and
COG KO cells. Western blot. (B) Quantification of GRP78 cleavage. (C) Time required for SubAB-dependent 50% cleavage of GRP78 in control and COG KO cells.
FIGURE 8 | Pro-cathepsin D is secreted from COG subunit KO cells but not WT cells. Cells at 80–100% confluency were placed in chemically defined serum
free media. Media was collected at 24 h and then analyzed by western blot for Cathepsin D.
of incubation with cells. We found that all cells lacking COG
subunits (with the exception of Cog6) but not the original
HEK293T cells secrete immature Cathepsin D (a lysosomal
protease), indicating defects in post-Golgi sorting and/or
endosome/lysosome impairments (Figure 8). Interestingly some,
but not all KOs also secrete a small amount of mature Cathepsin
D. Because Cog6 KOwas the only outlier for immature Cathepsin
D secretion we tested another Cog6 KO clone which yielded
a similar result (data not shown), though further analysis
of this cell line and generation and analysis of more Cog6
KO cell lines will be needed in the future to confirm this
finding.
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Cells Deficient in the COG Complex Show
Misglycosylated Lamp2, Reduced
Sialylation and Fucosylation, and Changes
in Oligomannose Composition
Increases in GNL binding to plasma membrane proteins, along
withmistargeting of CathepsinD indicate potential severe defects
in cellular lysosomal machinery and specifically in lysosomal
Lamp2 protein. Earlier we had noted Lamp 2 labeling large
endosomal like inclusions by IF in COG KO cells from lobe
A and B, so we decided to investigate this further. Lamp2
is a heavily glycosylated protein (10 O-linked and 16 N-
linked glycosylation sites, most of which are utilized), and is
primarily located on lysosomal membranes. It is thought to
help in lysosomal biogenesis and dynamics (Eskelinen et al.,
2002; Saftig and Klumperman, 2009). We used western blotting
to assess the glycosylation status of Lamp2 by assessing shifts
in the protein’s mobility. We have previously observed that
Lamp2 electrophoretic mobility is increased in cells treated
with siRNA to Cog3 and Cog7 (Shestakova et al., 2006).
Indeed, in cells lacking COG complex subunits Lamp2 had a
greatly increased mobility. This difference was not lobe specific,
though the absence of some subunits appears to cause a greater
increase in mobility than others (2, 3, 4, and 7 had the
highest mobility; Figure 9A). At the same time the majority of
hypoglycosylated Lamp2 was still properly localized to lysosome-
like intracellular structures as determined by colocalization with
Rab7a, indicating, indicating the trafficking of transmembrane
proteins and general lysosomal biogenesis is mostly undisturbed
in COG KO cells (Figure 9B).
To gain a better understanding of the changes in glycosylation
upon loss of individual COG subunits we further analyzed COG
KO cell lysates by using filter aided N-glycan Separation (Abdul
Rahman et al., 2014) followed by mass spectrometric N-glycan
profiling. For this analysis we chose Cog4 and 7 KOs to represent
the 2 lobes (we later chose to analyze Cog2 KO as well to
confirm the latter glycosylation impairments that were originally
thought to only occur in lobe B mutants). Profiling revealed
numerous glycosylation changes, the most prominent of which
are summarized in Figure 10. As observed previously for the
Cog1 and Cog2 deficient ldlB and ldlC CHO cell lines (Abdul
Rahman et al., 2014) the oligomannose distribution shifts in the
mutants, with a significant increase in the Man5GlcNAc2 species
and a concomitant decrease in the level of the Man6GlcNAc2
glycan (Figure 10A). The observed increase in the Man5 glycan
fits well with the increased GNL affinity of these cells, since this
glycan species has two terminal 1–3 linked mannose residues
(Shibuya et al., 1988). In addition to the increase in Man5 glycan
there is also a significant decrease in the Man9GlcNAc2 glycan’s
abundance, which was not observed in the CHO mutants. Other
functionally important changes are overall decreases in the levels
of sialylation (Figure 10B) and fucosylation (Figure 10C) in all
KO mutants analyzed. These are changes that often affect the
binding of important ligands to cell surface glycans. A decrease
in protein sialylation has been observed before in CDG-II patient
fibroblasts (Wu et al., 2004; Kranz et al., 2007; Zeevaert et al.,
2008), and defects in fucosylation have been seen in C. elegans
FIGURE 9 | Lamp2 is hypoglycosylated in COG subunit KO cells, but
still localizes to lysosome like structures. (A) Cell lysates were analyzed by
western blot for Lamp2 mobility. (B) WT and COG 2 KO cells were transfected
with Lamp2-mCherry and GFP-Rab7a. Arrows represent colocalization.
Asterisks represent large, late endocytic inclusions. Images taken of live cells.
Cog1 mutant (Struwe and Reinhold, 2012). Interestingly, all
observed glycosylation changes, nomatter if dependent on early-,
medial,- or late-Golgi processing steps, were very similar for Lobe
A (Cog2 and 4) and Lobe B (Cog7) knockouts, indicating that
the whole complex is needed for proper glycan processing to take
place.
DISCUSSION
As a result of this work a complete set of HEK293T cell lines
void of individual COG subunits was created. These cells are an
improvement on past KD and mutant studies as they are all in
the same cell type.We believe that this set will provide the unique
opportunity not only in the ongoing investigation of the specific
function of each individual subunit of this multifunctional MTC
but also as a starting reference point for detailed and unbiased
characterization of the other MTCs. Each COG KO cell line can
also be used to characterize (and potentially fix) glycosylation and
trafficking defects associated with naturally occurring mutations
in COG complex subunits that cause CDGII and other human
maladies.
Thus far all COG subunit knockouts have been shown to have:
altered G. nivalus lectin (GNL) binding to plasma membrane
glycoconjugates, altered binding and trafficking of toxins, cis,
medial, and trans-Golgi glycosylation defects, altered Golgi
morphology, and dramatic fragmentation of the trans Golgi
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FIGURE 10 | COG KO cells have global changes in N-linked glycans structures. N-glycans prepared from cell lysates were profiled by mass spectrometry. The
normalized intensities for individual glycans grouped into different classes as indicated were summed. Error bars show SEM for n = 4 (WT, Cog2KO), n = 5 (Cog4KO),
n = 8 (Cog7 KO). (A) Oligomannose composition changes in KO cells vs. WT cells. (B) Sialyation changes in KO cells vs. WT cells. **denotes p < 0.01. (C)
Fucosylation changes in KO cell vs. WT cells *denotes p < 0.05. For (B,C) one-way ANOVA with a Sidak-Holm post hoc statistical significance test was utilized.
network, altered Cathepsin D secretion, and hypoglycosylated
Lamp2.
As mentioned above, in ldlC (Cog2 deficient) CHO cells it
has previously been recognized that GM3 synthesis is impaired
(Spessott et al., 2010). GM3 is a precursor to GM1 (the binding
site for Cholera toxin) in the a-series ganglioside synthesis
pathway (Kolter et al., 2002). Spessott et al attributed this
reduction in GM3 synthesis to COG dependent mislocalization
of SialT1. Our COG KO cells show a global deficiency in
sialylation, making a similar reduction GM1 the most likely
explanation for our drastic reduction of Cholera toxin binding
in our human COG subunit deficient cells, but that this deserves
further investigation.
G. nivalus lectin (GNL) binding is known to be increased
in COG KD cells (Shestakova et al., 2006; Richardson et al.,
2009; Pokrovskaya et al., 2011; Willett R. A. et al., 2013; Ha
et al., 2014). We have shown that this increased lectin affinity
is also seen in CRISPR created COG KO populations (with
perhaps even a higher affinity than the COG KDs) and is
sufficient for effective FACS analysis and sorting to create clonal
COG KO populations. GNL binding shows a similar affinity
for all of the COG subunit KOs indicating substantial defects
in cis/medial-Golgi glycosylation when either lobe of the COG
complex is impaired. This contradicts the previous COG complex
models which suggest lobe A but not lobe B having a primary
role in cis/medial glycosylation (Reynders et al., 2009; Peanne
et al., 2011). Mass spectrometric analysis of the N-linked glycan
revealed further similarities in glycosylation defects between cells
deficient in all COG subunits tested so far (2,4,7), differing from
previous suggestions that lobe B is primarily responsible only for
the latter stages of glycosylation (Peanne et al., 2011; Laufman
et al., 2013).We have observed that each of our COGKO cell lines
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have the same characteristic alteration in their oligomannose
distributions, as well as impaired sialylation and fucosylation.
Due to observed glycosylation changes, we decided to analyze
a panel of Golgi and other secretory markers; GM130 (a
rod-like protein with coiled-coil domains located in the cis-
Golgi), TGN46 (a protein localized to the trans-Golgi network),
ERGIC53 (a mannose specific lectin carrier in the ER-Golgi
intermediate compartment), Giantin, Lamp2, and Mannose-
6 phosphate receptors were analyzed by immunofluorescence.
We observed no significant effect on localization of tested
Golgi or other secretory markers in COG KO cells at the IF
level, aside from large Lamp2 positive endocytic like inclusions
that were observed in addition to normal lysosomal Lamp2
distribution. Further observations revealed that Lamp2 is also
hypoglycosylated in COG KO cells. Though properly localized
aside for the endocytic inclusions, this hypoglycosylation could
result in altered lysosomal function or trafficking and will be an
interesting area of future investigation.
Following IF, more precise analysis of Golgi structure using
EM revealed that knocking out COG complex subunits causes
extensive dilation and fragmentation of the Golgi. Though all
subunits appear to be important for maintaining normal Golgi
structure, the level of Golgi dispersion is subunit dependent with
the lobe A KOs and Cog6 KO having the most disrupted Golgi
structure, indicating certain COG subunit interactions may be
more important for Golgi stacking than others.
We have observed Cog3, 4, 5, 6, 7, and 8 subunit levels in
each of the COG KOs. Lobe A KOs affect Cog3 and Cog4 levels
(Cog2, 3, and 4 KOs dramatically affected these, while Cog1
KO has much less impact). Lobe B KOs have little/no effect on
lobe A. Cog6 and 8, protein levels also affect their lobe partners
the most with Cog6 being most affected in Cog5, 6, and 7, and
Cog8 being most affected in Cog5 and 6 with Cog1 and Cog7
KOs being moderately affected. This Cog1 KO and Cog8 protein
effect is expected and gives further support to the Cog1-Cog8
bridging interaction (Ungar et al., 2005), which could also lend
stability to each of the proteins in vivo. Importantly, the dramatic
lobe specific effects on protein stability do not carry over to
the opposing lobe indicating that the similarity in phenotypes
between lobe A and lobe B subunit KOs is not due to instability
of the complex, but rather to the critical function of each lobe in
glycosylation and Golgi structure.
In line with impaired lysosomal trafficking and/or function
indicated by lamp2 hypoglycosylation, immature Cathepsin
D secretion was observed in COG complex subunit KOs.
Cathepsin D is a lysosomal aspartic protease that undergoes a
conformational change in the lysosome to become catalytically
active. Its inactive form has also been shown to have a role in
apoptosis. ProcathepsinD is also secreted from cancer cells where
it has a mitogenic effect on surrounding cells (Benes et al., 2008).
These results indicate that loss of COG function could affect
other aspects of the secretory pathway indirectly and change the
way organelles and cells function in their environment. To this
effect, we have also observed large intracellular accumulations
in the COG KO cells that appear to be of endocytic/phagocytic
origin. These accumulations appearmostly void of electron dense
material and, in the most severe cases take up ∼50% of the cells’
volume (Blackburn and Lupashin, data not shown).
In the future, these COG KO induced accumulations, and
how other subunit specific interactions (with SNAREs, Rabs, and
other tethers) are affected in COG complex subunit KO cells will
be an important area of investigation. Improper Golgi structure
and function is a hallmark of human diseases ranging from
cancers to Alzheimer’s. This makes further understanding the
key players of the secretory pathway, such as the COG complex
essential for human health.
AUTHOR CONTRIBUTIONS
JB wrote the article and made substantial contributions to
conception and design, acquisition of data, analysis, and
interpretation of data. IP participated in drafting the article,
performed electron microscopy, and interpreted the data. PF
participated in drafting the article, performed glycan analysis,
and interpreted the data. DU participated in drafting the article,
performed glycan analysis, and interpreted the data. VL wrote
the article and made substantial contributions to conception and
design, acquisition of data, analysis and interpretation of data.
ACKNOWLEDGMENTS
We are thankful to Horizon Discovery Group and Santiago M.
Di Pietro as well as others who provided reagents. We also
would like to thank Rose Willett for initial input and Tetyana
Kudlyk for excellent technical support. We would also like to
thank the UAMS sequencing, flow cytometry and microscopy
core facilities for the use of their facilities and expertise.
This work was supported by the National Institute of Health
(R01GM083144, U54 GM105814) (VL) and by the BBSRC DTP
grant BB/J014443/1 (DU).
REFERENCES
Abdul Rahman, S., Bergström, E., Watson, C. J., Wilson, K. M., Ashford,
D. A., Thomas, J. R., et al. (2014). Filter-aided N-glycan separation
(FANGS): a convenient sample preparation method for mass spectrometric
N-glycan profiling. J. Proteome Res. 13, 1167–1176. doi: 10.1021/pr40
1043r
Benes, P., Vetvicka, V., and Fusek M. (2008). Cathepsin D–many functions
of one aspartic protease. Crit. Rev. Oncol. Hematol. 68, 12–28. doi:
10.1016/j.critrevonc.2008.02.008
Climer, L. K., Dobretsov, M., and Lupashin, V. (2015). Defects in the COG complex
and COG-related trafficking regulators affect neuronal Golgi function. Front.
Neurosci. 9:405. doi: 10.3389/fnins.2015.00405
Cong, L., Ran, F. A., Cox, D., Lin, S., Barretto, R., Habib, N., et al. (2013). Multiplex
genome engineering using CRISPR/Cas systems. Science 339, 819–823. doi:
10.1126/science.1231143
Cottam, N. P., Wilson, K. M., Ng, B. G., Körner, C., Freeze, H. H., and
Ungar, D. (2014). Dissecting functions of the conserved oligomeric Golgi
tethering complex using a cell-free assay. Traffic 15, 12–21. doi: 10.1111/tra.
12128
Frontiers in Cell and Developmental Biology | www.frontiersin.org 14 March 2016 | Volume 4 | Article 23
Bailey Blackburn et al. Characterization of COG KO Cell Lines
Eskelinen, E.-L., Illert, A. L., Tanaka, Y., Schwarzmann, G., Blanz, J., Von Figura,
K., et al. (2002). Role of LAMP-2 in lysosome biogenesis and autophagy. Mol.
Biol. Cell 13, 3355–3368. doi: 10.1091/mbc.E02-02-0114
Fotso, P., Koryakina, Y., Pavliv, O., Tsiomenko, A. B., and Lupashin, V. V. (2005).
Cog1p plays a central role in the organization of the yeast conserved oligomeric
Golgi complex. J. Biol. Chem. 280, 27613–27623. doi: 10.1074/jbc.M504597200
Foulquier, F., Ungar, D., Reynders, E., Zeevaert, R., Mills, P., García-Silva,
M. T., et al. (2007). A new inborn error of glycosylation due to a Cog8
deficiency reveals a critical role for the Cog1-Cog8 interaction in COG complex
formation. Hum. Mol. Genet. 16, 717–730. doi: 10.1093/hmg/ddl476
Foulquier, F., Vasile, E., Schollen, E., Callewaert, N., Raemaekers, T., Quelhas, D.,
et al. (2006). Conserved oligomeric Golgi complex subunit 1 deficiency reveals
a previously uncharacterized congenital disorder of glycosylation type II. Proc.
Natl. Acad. Sci. U.S.A. 103, 3764–3769. doi: 10.1073/pnas.0507685103
Ha, J. Y., Pokrovskaya, I. D., Climer, L. K., Shimamura, G. R., Kudlyk, T., Jeffrey, P.
D., et al. (2014). Cog5-Cog7 crystal structure reveals interactions essential for
the function of a multisubunit tethering complex. Proc. Natl. Acad. Sci. U.S.A.
111, 15762–15767. doi: 10.1073/pnas.1414829111
Jinek, M., Chylinski, K., Fonfara, I., Hauer, M., Doudna, J. A., and Charpentier,
E. (2012). A programmable dual-RNA-guided DNA endonuclease in adaptive
bacterial immunity. Science 337, 816–821. doi: 10.1126/science.1225829
Kingsley, D. M., Kozarsky, K. F., Segal, M., and Krieger, M. (1986). Three types
of low density lipoprotein receptor-deficient mutant have pleiotropic defects in
the synthesis of N-linked, O-linked, and lipid- linked carbohydrate chains. J.
Cell Biol. 102, 1576–1585. doi: 10.1083/jcb.102.5.1576
Kodera, H., Ando, N., Yuasa, I., Wada, Y., Tsurusaki, Y., Nakashima, M., et al.
(2015). Mutations in COG2 encoding a subunit of the conserved oligomeric
golgi complex cause a congenital disorder of glycosylation. Clin. Genet. 87,
455–460. doi: 10.1111/cge.12417
Kolter, T., Proia, R. L., and Sandhoff, K. (2002). Combinatorial ganglioside
biosynthesis. J. Biol. Chem. 277, 25859–25862. doi: 10.1074/jbc.R200001200
Kranz, C., Ng, B. G., Sun, L., Sharma, V., Eklund, E. A., Miura, Y., et al. (2007).
COG8 deficiency causes new congenital disorder of glycosylation type IIh.
Hum. Mol. Genet. 16, 731–741. doi: 10.1093/hmg/ddm028
Kudlyk, T.,Willett, R., Pokrovskaya, I. D., and Lupashin, V. (2013). COG6 interacts
with a subset of the Golgi SNAREs and is important for the Golgi complex
integrity. Traffic 14, 194–204. doi: 10.1111/tra.12020
Laufman, O., Freeze, H. H., Hong, W., and Lev, S. (2013). Deficiency of the Cog8
subunit in normal and CDG-derived cells impairs the assembly of the COG and
Golgi SNARE complexes. Traffic 14, 1065–1077. doi: 10.1111/tra.12093
Lencer, W. I., Delp, C., Neutra, M. R., and Madara, J. L. (1992). Mechanism of
cholera toxin action on a polarized human intestinal epithelial cell line: role of
vesicular traffic. J. Cell Biol. 117, 1197–1209. doi: 10.1083/jcb.117.6.1197
Liu, S., Dominska-Ngowe, M., and Dykxhoorn, D. M. (2014). Target silencing
of components of the conserved oligomeric Golgi complex impairs HIV-1
replication. Virus Res. 192, 92–102. doi: 10.1016/j.virusres.2014.08.015
Lübbehusen, J., Thiel, C., Rind, N., Ungar, D., Prinsen, B. H., de Koning, T. J.,
et al. (2010). Fatal outcome due to deficiency of subunit 6 of the conserved
oligomeric Golgi complex leading to a new type of congenital disorders
of glycosylation. Hum. Mol. Genet. 19, 3623–3633. doi: 10.1093/hmg/d
dq278
Lupashin, V., and Sztul, E. (2005). Golgi tethering factors. Biochim. Biophys. Acta
1744, 325–339. doi: 10.1016/j.bbamcr.2005.03.013
Mali, P., Yang, L., Esvelt, K. M., Aach, J., Guell, M., Dicarlo, J. E., et al. (2013).
RNA-guided human genome engineering via Cas9. Science 339, 823–826. doi:
10.1126/science.1232033
Miller, V. J., Sharma, P., Kudlyk, T. A., Frost, L., Rofe, A. P., Watson, I. J., et al.
(2013). Molecular insights into vesicle tethering at the Golgi by the conserved
oligomeric Golgi (COG) complex and the golgin TATA element modulatory
factor (TMF). J. Biol. Chem. 288, 4229–4240. doi: 10.1074/jbc.M112.426767
Miller, V. J., and Ungar, D. (2012). Re’COG’nition at the Golgi. Traffic 13, 891–897.
doi: 10.1111/j.1600-0854.2012.01338.x
Oka, T., Ungar, D., Hughson, F. M., and Krieger, M. (2004). The COG and
COPI complexes interact to control the abundance of GEARs, a subset
of Golgi integral membrane proteins. Mol. Biol. Cell 15, 2423–2435. doi:
10.1091/mbc.E03-09-0699
Oka, T., Vasile, E., Penman, M., Novina, C. D., Dykxhoorn, D. M., Ungar,
D., et al. (2005). Genetic analysis of the subunit organization and function
of the conserved oligomeric golgi (COG) complex: studies of COG5- and
COG7-deficient mammalian cells. J. Biol. Chem. 280, 32736–32745. doi:
10.1074/jbc.M505558200
Paesold-Burda, P., Maag, C., Troxler, H., Foulquier, F., Kleinert, P., Schnabel,
S., et al. (2009). Deficiency in COG5 causes a moderate form of
congenital disorders of glycosylation. Hum. Mol. Genet. 18, 4350–4356. doi:
10.1093/hmg/ddp389
Paton, A. W., Srimanote, P., Talbot, U. M., Wang, H., and Paton, J. C. (2004). A
new family of potent AB(5) cytotoxins produced by Shiga toxigenic Escherichia
coli. J. Exp. Med. 200, 35–46. doi: 10.1084/jem.20040392
Peanne, R., Legrand, D., Duvet, S., Mir, A. M., Matthijs, G., Rohrer, J., et al.
(2011). Differential effects of lobe A and lobe B of the Conserved Oligomeric
Golgi complex on the stability of {beta}1,4-galactosyltransferase 1 and
{alpha}2,6-sialyltransferase 1. Glycobiology 21, 864–876. doi: 10.1093/glycob/c
wq176
Podos, S. D., Reddy, P., Ashkenas, J., and Krieger, M. (1994). LDLC encodes
a brefeldin A-sensitive, peripheral Golgi protein required for normal Golgi
function. J. Cell Biol. 127, 679–691. doi: 10.1083/jcb.127.3.679
Pokrovskaya, I. D., Szwedo, J.W., Goodwin, A., Lupashina, T. V., Nagarajan, U.M.,
and Lupashin, V. V. (2012). Chlamydia trachomatis hijacks intra-Golgi COG
complex-dependent vesicle trafficking pathway. Cell. Microbiol. 14, 656–668.
doi: 10.1111/j.1462-5822.2012.01747.x
Pokrovskaya, I. D., Willett, R., Smith, R. D., Morelle, W., Kudlyk, T., and Lupashin,
V. V. (2011). Conserved oligomeric Golgi complex specifically regulates the
maintenance of Golgi glycosylation machinery. Glycobiology 21, 1554–1569.
doi: 10.1093/glycob/cwr028
Reynders, E., Foulquier, F., Leão Teles, E., Quelhas, D., Morelle, W., Rabouille,
C., et al. (2009). Golgi function and dysfunction in the first COG4-deficient
CDG type II patient. Hum. Mol. Genet. 18, 3244–3256. doi: 10.1093/hmg/d
dp262
Richardson, B. C., Smith, R. D., Ungar, D., Nakamura, A., Jeffrey, P. D., Lupashin,
V. V., et al. (2009). Structural basis for a human glycosylation disorder caused
by mutation of the COG4 gene. Proc. Natl. Acad. Sci. U.S.A. 106, 13329–13334.
doi: 10.1073/pnas.0901966106
Rymen, D., Winter, J., Van Hasselt, P. M., Jaeken, J., Kasapkara, C., Gokçay, G.,
et al. (2015). Key features and clinical variability of COG6-CDG. Mol. Genet.
Metab. 116, 163–170. doi: 10.1016/j.ymgme.2015.07.003
Saftig, P., and Klumperman, J. (2009). Lysosome biogenesis and lysosomal
membrane proteins: trafficking meets function. Nat. Rev. Mol. Cell Biol. 10,
623–635. doi: 10.1038/nrm2745
Shestakova, A., Suvorova, E., Pavliv, O., Khaidakova, G., and Lupashin, V.
(2007). Interaction of the conserved oligomeric Golgi complex with t-SNARE
Syntaxin5a/Sed5 enhances intra-Golgi SNARE complex stability. J. Cell Biol.
179, 1179–1192. doi: 10.1083/jcb.200705145
Shestakova, A., Zolov, S., and Lupashin, V. (2006). COG complex-mediated
recycling of Golgi glycosyltransferases is essential for normal protein
glycosylation. Traffic 7, 191–204. doi: 10.1111/j.1600-0854.2005.00376.x
Shibuya, N., Goldstein, I. J., Van Damme, E. J., and Peumans, W. J. (1988). Binding
properties of a mannose-specific lectin from the snowdrop (Galanthus nivalis)
bulb. J. Biol. Chem. 263, 728–734.
Smith, R. D.,Willett, R., Kudlyk, T., Pokrovskaya, I., Paton, A.W., Paton, J. C., et al.
(2009). The COG complex, Rab6 and COPI define a novel Golgi retrograde
trafficking pathway that is exploited by SubAB toxin. Traffic 10, 1502–1517.
doi: 10.1111/j.1600-0854.2009.00965.x
Sohda, M., Misumi, Y., Yamamoto, A., Nakamura, N., Ogata, S., Sakisaka, S.,
et al. (2010). Interaction of Golgin-84 with the COG complex mediates the
intra-Golgi retrograde transport. Traffic 11, 1552–1566. doi: 10.1111/j.1600-
0854.2010.01123.x
Sohda, M., Misumi, Y., Yoshimura, S., Nakamura, N., Fusano, T., Ogata, S.,
et al. (2007). The interaction of two tethering factors, p115 and COG
complex, is required for Golgi integrity. Traffic 8, 270–284. doi: 10.1111/j.1600-
0854.2006.00530.x
Spessott, W., Uliana, A., and MacCioni, H. J. (2010). Defective GM3 synthesis in
Cog2 null mutant CHO cells associates to mislocalization of lactosylceramide
sialyltransferase in the Golgi complex. Neurochem. Res. 35, 2161–2167. doi:
10.1007/s11064-010-0319-8
Stanley, P. (2011). Golgi glycosylation. Cold Spring Harb. Perspect. Biol. 3:a005199.
doi: 10.1101/cshperspect.a005199
Frontiers in Cell and Developmental Biology | www.frontiersin.org 15 March 2016 | Volume 4 | Article 23
Bailey Blackburn et al. Characterization of COG KO Cell Lines
Steet, R., and Kornfeld, S. (2006). COG-7-deficient human fibroblasts exhibit
altered recycling of golgi proteins. Mol. Biol. Cell 17, 2312–2321. doi:
10.1091/mbc.E05-08-0822
Struwe, W. B., and Reinhold, V. N. (2012). The conserved oligomeric Golgi
complex is required for fucosylation of N-glycans in Caenorhabditis elegans.
Glycobiology 22, 863–875. doi: 10.1093/glycob/cws053
Sun, Y., Shestakova, A., Hunt, L., Sehgal, S., Lupashin, V., and Storrie, B. (2007).
Rab6 regulates both ZW10/RINT-1 and conserved oligomeric Golgi complex-
dependent Golgi trafficking and homeostasis.Mol. Biol. Cell 18, 4129–4142. doi:
10.1091/mbc.E07-01-0080
Suvorova, E. S., Duden, R., and Lupashin, V. V. (2002). The Sec34/Sec35p complex,
a Ypt1p effector required for retrograde intra-Golgi trafficking, interacts with
Golgi SNAREs and COPI vesicle coat proteins. J. Cell Biol. 157, 631–643. doi:
10.1083/jcb.200111081
Suvorova, E. S., Kurten, R. C., and Lupashin, V. V. (2001). Identification of
a human orthologue of Sec34p as a component of the cis-Golgi vesicle
tethering machinery. J. Biol. Chem. 276, 22810–22818. doi: 10.1074/jbc.M0116
24200
Ungar, D. (2009). Golgi linked protein glycosylation and associated
diseases. Semin. Cell Dev. Biol. 20, 762–769. doi: 10.1016/j.semcdb.2009.
03.004
Ungar, D., Oka, T., Brittle, E. E., Vasile, E., Lupashin, V. V., Chatterton, J. E., et al.
(2002). Characterization of a mammalian Golgi-localized protein complex,
COG, that is required for normal Golgi morphology and function. J. Cell Biol.
157, 405–415. doi: 10.1083/jcb.200202016
Ungar, D., Oka, T., Vasile, E., Krieger, M., and Hughson, F. M. (2005). Subunit
architecture of the conserved oligomeric Golgi complex. J. Biol. Chem. 280,
32729–32735. doi: 10.1074/jbc.M504590200
Vasile, E., Oka, T., Ericsson, M., Nakamura, N., and Krieger, M. (2006). IntraGolgi
distribution of the Conserved Oligomeric Golgi (COG) complex. Exp. Cell Res.
312, 3132–3141. doi: 10.1016/j.yexcr.2006.06.005
Whyte, J. R. C., and Munro, S. (2001). The SeC34/35 golgi transport complex
is related to the exocyst, defining a family of complexes involved in multiple
steps of membrane traffic.Dev. Cell 1, 527–537. doi: 10.1016/S1534-5807(01)00
063-6
Willett, R., Kudlyk, T., Pokrovskaya, I., Schönherr, R., Ungar, D.,
Duden, R., et al. (2013a). COG complexes form spatial landmarks
for distinct SNARE complexes. Nat. Commun. 4, 1553. doi: 10.1038/
ncomms2535
Willett, R., Pokrovskaya, I., Kudlyk, T., and Lupashin, V. (2014). Multipronged
interaction of the COG complex with intracellular membranes. Cell. Logist.
4:e27888. doi: 10.4161/cl.27888
Willett, R., Ungar, D., and Lupashin, V. (2013b). The Golgi puppet master: COG
complex at center stage of membrane trafficking interactions. Histochem. Cell
Biol. 140, 271–283. doi: 10.1007/s00418-013-1117-6
Willett, R. A., Pokrovskaya, I. D., and Lupashin, V. V. (2013). Fluorescent
microscopy as a tool to elucidate dysfunction and mislocalization of Golgi
glycosyltransferases in COG complex depleted mammalian cells.Methods Mol.
Biol. 1022, 61–72. doi: 10.1007/978-1-62703-465-4_6
Wu, X., Steet, R. A., Bohorov, O., Bakker, J., Newell, J., Krieger, M., et al. (2004).
Mutation of the COG complex subunit gene COG7 causes a lethal congenital
disorder. Nat. Med. 10, 518–523. doi: 10.1038/nm1041
You, W. K., Kasman, I., Hu-Lowe, D. D., and McDonald, D. M. (2010). Ricinus
communis agglutinin I leads to rapid down-regulation of VEGFR-2 and
endothelial cell apoptosis in tumor blood vessels.Am. J. Pathol. 176, 1927–1940.
doi: 10.2353/ajpath.2010.090561
Yu, I. M., and Hughson, F. M. (2010). Tethering factors as organizers of
intracellular vesicular traffic. Annu. Rev. Cell Dev. Biol. 26, 137–156. doi:
10.1146/annurev.cellbio.042308.113327
Zeevaert, R., Foulquier, F., Jaeken, J., and Matthijs, G. (2008). Deficiencies in
subunits of the Conserved Oligomeric Golgi (COG) complex define a novel
group of congenital disorders of glycosylation. Mol. Genet. Metab. 93, 15–21.
doi: 10.1016/j.ymgme.2007.08.118
Zolov, S. N., and Lupashin, V. V. (2005). Cog3p depletion blocks vesicle-mediated
Golgi retrograde trafficking in HeLa cells. J. Cell Biol. 168, 747–759. doi:
10.1083/jcb.200412003
Conflict of Interest Statement: The authors declare that the research was
conducted in the absence of any commercial or financial relationships that could
be construed as a potential conflict of interest.
Copyright © 2016 Bailey Blackburn, Pokrovskaya, Fisher, Ungar and Lupashin.
This is an open-access article distributed under the terms of the Creative Commons
Attribution License (CC BY). The use, distribution or reproduction in other forums
is permitted, provided the original author(s) or licensor are credited and that the
original publication in this journal is cited, in accordance with accepted academic
practice. No use, distribution or reproduction is permitted which does not comply
with these terms.
Frontiers in Cell and Developmental Biology | www.frontiersin.org 16 March 2016 | Volume 4 | Article 23
